Viewing Study NCT02224820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-01 @ 10:50 PM
Study NCT ID: NCT02224820
Status: COMPLETED
Last Update Posted: 2017-03-03
First Post: 2014-08-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease
Sponsor: Hansa Biopharma AB
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None transplantation View
None sensitised patients View
None HLA-antibodies View